Skip to main content
S&P 5007,683.69-0.77%DOW51,481.51-0.67%NASDAQ26,820.38-0.92%BTC$83,503.00-0.83%ETH$2,685.81+0.39%GOLD$4,156.50-0.29%OIL$93.34+0.80%
Smart Investors Daily
IP

OTC · IPSEY

Ipsen S.A.

Healthcare · Drug Manufacturers - Specialty & Generic

$40.89

Down-$1.09 (-2.60%)

Updated Sep 28, 2026, 11:00 PM

SID Score

6.2/10

Composite research score

Smart Money

46/100

Neutral

Market cap
47.01B
P/E ratio
22.47
Dividend yield
0.98%
52-week range
$25.11 – $51.10
Volume
106
Avg. volume
1.58K

Price performance · IPSEY

IPSEY price history

1M range · 7 trading sessions · Daily adjusted prices

Prices through Sep 23, 2026

IPSEY closed at $41.97 after 7 trading sessions, down 8.58% for the selected period.

Last close
$41.97
Period change
-8.58%
Period low
$41.97
Period high
$46.50
Daily close
View OHLC price history
IPSEY OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 23, 2026$41.97$41.97$41.97$41.97106
Sep 21, 2026$42.408$42.408$42.408$42.408241
Sep 17, 2026$44.82$44.82$44.75$44.75266
Sep 16, 2026$46.228$46.228$46.228$46.228408
Sep 14, 2026$45.92$45.92$45.92$45.92235
Sep 9, 2026$46.50$46.50$46.50$46.50215
Sep 8, 2026$45.91$45.91$45.91$45.9110.28K

Latest IPSEY news

The latest Smart Investors Daily articles mentioning IPSEY.

Stock researchCompany · Overview

IPSEY research

Overview

Company profile and research snapshot.

Company profile

IPSEN SA S/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
—
Implied upside
—
Analysts
6
IPSEY recent ratings
DateFirmRatingTarget
Sep 20, 2026JEFFERIESUnderperform—
Sep 18, 2026BAADER EUROPE / ALPHAVALUEBuy—
Aug 31, 2026BNP PARIBASNeutral—
Aug 4, 2026ESN/CIC MARKET SOLUTIONSBuy—
Aug 4, 2026ROTHSCHILD & CO REDBURNBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 25, 2026

Ipsen (ENXTPA:IPN) Could Be 11% Undervalued Following Board Changes

Ipsen (ENXTPA:IPN) has refreshed its governance, with the board appointing Mariette Finet as Director and member of the Board Portfolio Committee following Michèle Ollier’s resignation earlier in the summer. Ipsen’s share price has softened in the short term, with a 1-month share price return down 10.18% and a 7-day move lower by 4.30%. The stock is still up 28.42% year to date and has delivered a 35.14% total shareholder return over the past year, suggesting longer term momentum remains...

Yahoo · Sep 22, 2026

IPSEN - Buy-back programme - Art 5 of MAR - Week 38 - 2026

Aggregated presentation by day and by market Weekly report on share repurchases from 14th September to 18th September 2026 Name of the IssuerIdentify code of the IssuerTransaction dayIdentify code of the financial instrumentTotal daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code)IPSEN549300M6SGDPB4Z94P1114/09/2026FR001025915000-IPSEN549300M6SGDPB4Z94P1115/09/2026FR001025915000-IPSEN549300M6SGDPB4Z94P1116/09/2026FR001025915000-IPSEN549300M6SGDPB

Yahoo · Sep 18, 2026

Ipsen appoints Mariette Finet to its Board of Directors

Ipsen appoints Mariette Finet to its Board of Directors PARIS, FRANCE, 18 SEPTEMBER 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the co-optation of Mariette Finet as a Director to its Board of Directors, effective immediately. Ms. Finet succeeds Ms. Michèle Ollier, who resigned from her position as Director on 1 August 2026. A Doctor of Medicine and graduate of the University of Nancy, Ms. Finet brings more than 35 years of experience across the healthcare, pharmaceutical and life sc

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By